Literature DB >> 33337371

Communicating 5-Year Risk of Alzheimer's Disease Dementia: Development and Evaluation of Materials that Incorporate Multiple Genetic and Biomarker Research Results.

Jessica Mozersky1, Sarah Hartz2, Erin Linnenbringer3, Lillie Levin1, Marissa Streitz4, Kristin Stock5, Krista Moulder4, John C Morris4.   

Abstract

BACKGROUND: Cognitively normal (CN) older adults participating in Alzheimer's disease (AD) research increasingly ask for their research results-including genetic and neuroimaging findings-to understand their risk of developing AD dementia. AD research results are typically not returned for multiple reasons, including possible psychosocial harms of knowing one is at risk of a highly feared and untreatable disease.
OBJECTIVE: We developed materials that convey information about 5-year absolute risk of developing AD dementia based on research results.
METHODS: 20 CN older adults who received a research brain MRI result were interviewed regarding their wishes for research results to inform material development (Pilot 1). Following material development, 17 CN older adults evaluated the materials for clarity and acceptability (Pilot 2). All participants were community-dwelling older adults participating in longitudinal studies of aging at a single site.
RESULTS: Participants want information on their risk of developing AD dementia to better understand their own health, satisfy curiosity, inform family, and future planning. Some articulated concerns, but the majority wanted to know their risk despite the limitations of information. Participants found the educational materials and results report clear and acceptable, and the majority would want to know their research results after reviewing them.
CONCLUSION: These materials will be used in a clinical study examining the psychosocial and cognitive effects of offering research results to a cohort of CN older adults. Future AD research may incorporate the return of complex risk information to CN older adults, and materials are needed to communicate this information.

Entities:  

Keywords:  Alzheimer’s disease dementia; biomarkers; cognitively normal older adults; genetics; health communication; imaging; pre-symptomatic; research ethics; return of research results; risk

Mesh:

Substances:

Year:  2021        PMID: 33337371      PMCID: PMC7877232          DOI: 10.3233/JAD-200993

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  71 in total

1.  Inequalities in dementia incidence between six racial and ethnic groups over 14 years.

Authors:  Elizabeth Rose Mayeda; M Maria Glymour; Charles P Quesenberry; Rachel A Whitmer
Journal:  Alzheimers Dement       Date:  2016-02-11       Impact factor: 21.566

2.  Disclosing individual genetic results to research participants.

Authors:  Vardit Ravitsky; Benjamin S Wilfond
Journal:  Am J Bioeth       Date:  2006 Nov-Dec       Impact factor: 11.229

3.  APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.

Authors:  John C Morris; Catherine M Roe; Chengjie Xiong; Anne M Fagan; Alison M Goate; David M Holtzman; Mark A Mintun
Journal:  Ann Neurol       Date:  2010-01       Impact factor: 10.422

4.  A new initiative on precision medicine.

Authors:  Francis S Collins; Harold Varmus
Journal:  N Engl J Med       Date:  2015-01-30       Impact factor: 91.245

Review 5.  Sociodemographic, psychosocial and clinical factors associated with uptake of genetic counselling for hereditary cancer: a systematic review.

Authors:  A M Willis; S K Smith; B Meiser; M L Ballinger; D M Thomas; M-A Young
Journal:  Clin Genet       Date:  2016-10-23       Impact factor: 4.438

6.  Public perceptions of presymptomatic testing for Alzheimer disease.

Authors:  Richard J Caselli; Jessica Langbaum; Gary E Marchant; Rachel A Lindor; Katherine S Hunt; Bruce R Henslin; Amylou C Dueck; Jason S Robert
Journal:  Mayo Clin Proc       Date:  2014-08-26       Impact factor: 7.616

Review 7.  NIA-AA Research Framework: Toward a biological definition of Alzheimer's disease.

Authors:  Clifford R Jack; David A Bennett; Kaj Blennow; Maria C Carrillo; Billy Dunn; Samantha Budd Haeberlein; David M Holtzman; William Jagust; Frank Jessen; Jason Karlawish; Enchi Liu; Jose Luis Molinuevo; Thomas Montine; Creighton Phelps; Katherine P Rankin; Christopher C Rowe; Philip Scheltens; Eric Siemers; Heather M Snyder; Reisa Sperling
Journal:  Alzheimers Dement       Date:  2018-04       Impact factor: 21.566

8.  Alzheimer's Prevention Initiative Generation Program: Development of an APOE genetic counseling and disclosure process in the context of clinical trials.

Authors:  Carolyn M Langlois; Angela Bradbury; Elisabeth M Wood; J Scott Roberts; Scott Y H Kim; Marie-Emmanuelle Riviere; Fonda Liu; Eric M Reiman; Pierre N Tariot; Jason Karlawish; Jessica B Langbaum
Journal:  Alzheimers Dement (N Y)       Date:  2019-11-06

Review 9.  Recruitment and retention of underrepresented populations in Alzheimer's disease research: A systematic review.

Authors:  Andrea L Gilmore-Bykovskyi; Yuanyuan Jin; Carey Gleason; Susan Flowers-Benton; Laura M Block; Peggye Dilworth-Anderson; Lisa L Barnes; Manish N Shah; Megan Zuelsdorff
Journal:  Alzheimers Dement (N Y)       Date:  2019-11-19

10.  High-precision plasma β-amyloid 42/40 predicts current and future brain amyloidosis.

Authors:  Suzanne E Schindler; James G Bollinger; Vitaliy Ovod; Kwasi G Mawuenyega; Yan Li; Brian A Gordon; David M Holtzman; John C Morris; Tammie L S Benzinger; Chengjie Xiong; Anne M Fagan; Randall J Bateman
Journal:  Neurology       Date:  2019-08-01       Impact factor: 11.800

View more
  2 in total

1.  Return of individual research results from genomic research: A systematic review of stakeholder perspectives.

Authors:  Danya F Vears; Joel T Minion; Stephanie J Roberts; James Cummings; Mavis Machirori; Mwenza Blell; Isabelle Budin-Ljøsne; Lorraine Cowley; Stephanie O M Dyke; Clara Gaff; Robert Green; Alison Hall; Amber L Johns; Bartha M Knoppers; Stephanie Mulrine; Christine Patch; Eva Winkler; Madeleine J Murtagh
Journal:  PLoS One       Date:  2021-11-08       Impact factor: 3.240

2.  Disclosure of individual research results at federally funded Alzheimer's Disease Research Centers.

Authors:  J Scott Roberts; Rebecca Ferber; Deborah Blacker; Malia Rumbaugh; Joshua D Grill
Journal:  Alzheimers Dement (N Y)       Date:  2021-10-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.